BRKR
Medical Devices · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when Bruker Corp publishes a filing, an earnings call transcript or a press release.
Get BRKR alertsGerald Herman is recorded as CFO at Bruker Corp (BRKR). The newest filing on record that lists Gerald Herman as CFO at Bruker Corp (BRKR) is dated April 10, 2026. The proxy statement of Bruker Corp reports total compensation of $2,010,308 for Gerald Herman in fiscal 2025, including a base salary of $644,234. Disclosed compensation is on record for 8 fiscal years. Gerald Herman has spoken on 26 earnings calls and 3 other investor events across 1 company, most recently for Bruker Corp on September 16, 2026. Bruker Corp is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at Bruker Corp includes Burkhard A. Prause (CEO), Frank Laukien (CEO), Thomas Bures (Chief Accounting Officer) and 7 others.
“I don't think our capital allocation decisions have really changed. I mean, most of our capital is being deployed for innovation in the R&D field.”
“I'm pleased to provide more detail on Brooker's second quarter and first half 2026 financial performance, starting on slide 11. In the second quarter of 2026, our results came in at the low end of our expectations on the top line, but meaningfully ahead of expectations on margins in EPS.”
“We had good, strong order performance in the first quarter, coming off a fairly good performance on orders in Q4. So I think actually at a high level, we are sort of moving into the third quarter.”
“I'm pleased to provide more detail on Brooker's first quarter 2026 financial performance, starting on slide 11. Despite significant macro and foreign exchange headwinds in the quarter, we delivered financial performance ahead of expectations we outlined in our earnings call in February.”
“Before I get into the details of our financial performance, I wanted to provide a high-level view of how the fourth quarter played out versus our expectations at the time of our last earnings call.”
Start not stated–present
Last confirmed April 10, 2026
BRKR
Medical Devices · Healthcare
CFO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Bruker Corp (BRKR) | Executive Vice President and Chief Financial Officer | $644,234 | $2,010,308 |
| 2024 | Bruker Corp (BRKR) | Executive Vice President and Chief Financial Officer | $635,385 | $2,288,269 |
| 2023 | Bruker Corp (BRKR) | Executive Vice President and Chief Financial Officer | $603,538 | $2,204,302 |
| 2022 | Bruker Corp (BRKR) | Executive Vice President and Chief Financial Officer | $570,982 | $1,898,666 |
| 2021 | Bruker Corp (BRKR) | Executive Vice President and Chief Financial Officer | $545,310 | $1,940,547 |
| 2020 | Bruker Corp (BRKR) | Executive Vice President and Chief Financial Officer | $446,148 | $1,303,121 |
| 2019 | Bruker Corp (BRKR) | Executive Vice President and Chief Financial Officer | $443,019 | $1,248,193 |
| 2018 | Bruker Corp (BRKR) | Chief Financial Officer | $360,939 | $1,026,521 |